{"store":{"baseInfo":{"podcastTitle":"The HemOnc Pulse","slug":"hemoncpulse","podcastDescription":"Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","podcastUrl":"https://hemoncpulse.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/hemoncpulse/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-gbcct-110b233?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":65,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Rahul Banerjee, MD","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-gbcct-110b233-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-gbcct-110b233?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/r1zV1nCvRuqN","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-W6nWPbI0puz9","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2025 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://hemoncpulse.podbean.com","apiCommonParams":{"t":"6861fc2d","clientSignature":"3b4990aa8f12204412c9fe3fe4a357b4","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb26000118-vm8fk","episode":{"id":"pb26000118","idTag":"vm8fk","title":"The 'HemOnc Pulse Live' Controversies in Aggressive NHL","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","previewContent":null,"content":"

In this HemOnc Pulse Live! edition of podcast, Dr. Mehdi Hamadani leads a comprehensive panel discussion on controversies and unanswered questions in the treatment of aggressive non-Hodgkin lymphoma. Dr. Hamadani is joined by Drs. Timothy Fenske, Madiha Iqbal, Urshila Durani, and Mohamed Kharfan-Dabaja.

","publishTimestamp":1749099600,"duration":87000,"mediaUrl":"https://mcdn.podbean.com/mf/web/sa5tnt5r237hwphj/The_HemOnc_Pulse_AGGRESSIVE_NHL_V18vm09.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-vm8fk-18cbaf6","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-vm8fk-18cbaf6","transcriptUrl":null,"permalink":"/e/the-hemonc-pulse-live-controversies-in-aggressive-nhl/","downloadLink":"https://www.podbean.com/media/share/pb-vm8fk-18cbaf6?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":195,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-vm8fk-18cbaf6","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fhemoncpulse.podbean.com%252Fe%252Fthe-hemonc-pulse-live-controversies-in-aggressive-nhl%252F&rts=fdae50589ec2a0de731c3d811a4c16a7976615d6","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb26000118","idTag":"vm8fk","title":"The 'HemOnc Pulse Live' Controversies in Aggressive NHL","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","previewContent":null,"content":"